Concepedia

Publication | Open Access

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

37

Citations

22

References

2020

Year

References

YearCitations

Page 1